Clinical Trial Update: Lapatinib in Combination With Weekly Paclitaxel in Patients With ErbB2 Amplified Advanced Gastric Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial of lapatinib in combination with weekly paclitaxel for ErbB2-amplified advanced gastric cancer has completed and posted its results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• Lapatinib (Lapatinib)
• Taxol (paclitaxel)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Neoplasms, Gastrointestinal Tract | Phase 3 | Status: COMPLETED | Results posted: 2013-02-07